Literature DB >> 35829934

Incidence of other cancer diagnoses in women with breast cancer: a retrospective cohort study with 42,248 women.

Ivan Nikolov1, Karel Kostev2, Matthias Kalder3.   

Abstract

PURPOSE: The aim of the present study was to determine whether women diagnosed with breast cancer (BC) have an increased incidence of other cancers, e.g., gastric cancer, lung cancer, skin cancer, and so on, compared to healthy women without a breast cancer diagnosis.
METHODS: This retrospective cohort study was based on data from the Disease Analyzer database (IQVIA) and included adult women with an initial diagnosis of BC documented in one of 1,274 general practices in Germany between January 2000 and December 2018. Women with BC were matched to women without cancer by age, index year, yearly consultation frequency, and co-diagnoses. Univariate Cox regression models were used to study the association between BC and the incidence of other cancer diagnoses.
RESULTS: 21,124 women with BC and 21,124 women (mean age: 63 years) without cancer were included. Within 10 years of the index date, 14.3% of women with BC and 10.0% of women without cancer were diagnosed with cancer (p < 0.001). BC was significantly associated with the incidence of other cancer diagnoses (HR: 1.42, p < 0.001). The strongest association was observed for respiratory organ cancer (HR = 1.69, p < 0.001), followed by female genital organ cancer (HR = 1.61, p < 0.001) and cancer of lymphoid and hematopoietic tissue (HR: 1.59, p < 0.001).
CONCLUSION: The results of this study show that women with BC have an increased incidence of another cancer compared to women without cancer. Therefore, it is important to pay particular attention to the development of other malignancies during follow-up in patients with BC. This should be considered especially in patients with a proven genetic mutation.
© 2022. The Author(s), under exclusive licence to Springer Science+Business Media, LLC, part of Springer Nature.

Entities:  

Keywords:  Breast cancer; Cancer of lymphoid and hematopoietic tissue; Respiratory organ cancer; Retrospective cohort study

Mesh:

Year:  2022        PMID: 35829934     DOI: 10.1007/s10549-022-06666-5

Source DB:  PubMed          Journal:  Breast Cancer Res Treat        ISSN: 0167-6806            Impact factor:   4.624


  40 in total

Review 1.  Management of hereditary breast and ovarian cancer.

Authors:  Hideko Yamauchi; Junko Takei
Journal:  Int J Clin Oncol       Date:  2017-11-28       Impact factor: 3.402

2.  Association between thyroid gland diseases and breast cancer: a case-control study.

Authors:  Laura Bach; Karel Kostev; Leif Schiffmann; Matthias Kalder
Journal:  Breast Cancer Res Treat       Date:  2020-05-18       Impact factor: 4.872

Review 3.  Cowden's disease.

Authors:  D S Bardenstein; I W McLean; J Nerney; R S Boatwright
Journal:  Ophthalmology       Date:  1988-08       Impact factor: 12.079

Review 4.  Epidemiology of Breast Cancer in Women.

Authors:  Steven S Coughlin
Journal:  Adv Exp Med Biol       Date:  2019       Impact factor: 2.622

Review 5.  [Update on Li-Fraumeni syndrome].

Authors:  C M Dutzmann; J Vogel; C P Kratz; K W Pajtler; S M Pfister; B B Dörgeloh
Journal:  Pathologe       Date:  2019-11       Impact factor: 1.011

Review 6.  The Role of BRCA Testing in Hereditary Pancreatic and Prostate Cancer Families.

Authors:  Robert Pilarski
Journal:  Am Soc Clin Oncol Educ Book       Date:  2019-05-17

Review 7.  Breast Cancer Risk Assessment: Moving Beyond BRCA 1 and 2.

Authors:  Jennifer Scalia-Wilbur; Bradley L Colins; Richard T Penson; Don S Dizon
Journal:  Semin Radiat Oncol       Date:  2015-09-04       Impact factor: 5.934

8.  Association between various thyroid gland diseases, TSH values and thyroid cancer: a case-control study.

Authors:  Leif Schiffmann; Karel Kostev; Matthias Kalder
Journal:  J Cancer Res Clin Oncol       Date:  2020-06-09       Impact factor: 4.553

9.  Basic characteristics and representativeness of the German Disease Analyzer database
.

Authors:  Wolfgang Rathmann; Brenda Bongaerts; Hans-Joachim Carius; Silvia Kruppert; Karel Kostev
Journal:  Int J Clin Pharmacol Ther       Date:  2018-10       Impact factor: 1.366

Review 10.  Hereditary breast and ovarian cancer (HBOC): review of its molecular characteristics, screening, treatment, and prognosis.

Authors:  Reiko Yoshida
Journal:  Breast Cancer       Date:  2020-08-29       Impact factor: 4.239

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.